pm-drug addiction

Drug Addiction Treatment Act

  • Significant legislation affecting the treatment of opioid addiction.
  • Prior to 2000, Physician Assistants (PAs) and other non-MD providers were not permitted to provide treatment for opioid addiction.
  • The Drug Addiction Treatment Act enabled PAs and Nurse Practitioners (NPs) to prescribe treatments like buprenorphine in outpatient settings.
  • This expansion has led to increased treatment options available outside clinical settings, significantly affecting PAs' roles in addiction treatment.

Buprenorphine and Its Role in Treatment

  • Buprenorphine is classified as a mild opioid agonist.
  • It is recognized as the standard of care for many patients suffering from severe opioid addiction.
  • Compared to stronger agonists, buprenorphine's effects are milder, reducing the risk of addiction.
  • Commonly dispensed in combination with naloxone under the brand name Suboxone.
  • The introduction of buprenorphine has transformed the treatment landscape, improving patients' functionality in family and societal roles.
  • Patients are more capable of maintaining employment and engaging with their communities, marking a significant shift in treatment outcomes.

Stimulants

  • Characterized as activators, stimulants increase alertness and energy levels.
  • Common examples include:
    • Cocaine
    • Crack cocaine
    • Amphetamines
  • Physiological effects include:
    • Dilated pupils
    • Increased heart rate, blood pressure, and respiratory rate
  • Potential adverse effects include:
    • Anxiety crises
    • Delusions
    • Agitation and hallucinations
    • Convulsions and coma
  • Withdrawal can result in:
    • Apathy
    • Sleepiness and depression
  • Long-term use contributes to chronic health problems like high blood pressure and heart disease, specifically dilated cardiomyopathy.

Depressants

  • Similar to alcohol, depressants gradually reduce activity in brain centers, leading to relaxation and a sense of numbness to the stresses of life.
  • High risk for abuse and addiction.
  • Sleep disturbances are common.
  • Benzodiazepines are particularly problematic due to the risk of coma and respiratory arrest in overdose situations.
  • Example: Diazepam is risky because it requires consuming large quantities to reach a lethal dose, but overdose is still possible.

Inhalants

  • Inhalants consist of easily accessible chemicals such as:
    • Paint thinner
    • Correction fluid
  • Commonly misused by teenagers, leading to toxic inhalation.
  • Mode of use involves inhaling vapors, which can lead to severe cellular damage.
  • Effects include:
    • Brain damage
    • Lung damage
    • Damage to mucosa in sinuses and nose
  • Continuous exposure can depress mental state, causing drowsiness and low consciousness.

Hallucinogens

  • Hallucinogens induce hallucinations and perceptual disturbances, often sought by individuals seeking creative inspiration.
  • Examples include:
    • PCP
    • Mescaline
    • Peyote
  • May result in psychotic symptoms, behavioral changes, and in some cases, chronic flashbacks even after cessation.
  • Historically associated with the 1960s counterculture but have resurfaced in current use.

Cannabis

  • Legal in many states, but still poses risks for abuse.
  • Known to provide euphoria and relaxation, with effects dependent on dosage.
  • Can have medicinal properties, especially in chronic pain management.
  • Risk of addiction exists, and chronic use is associated with schizophrenia in approximately one-third of cases.
  • Withdrawal syndrome symptoms include hyperactivity, insomnia, and loss of appetite.
  • Edibles, including brownies and candy, pose a risk to children and pets, with notable cases of poisoning.

Steroids

  • Steroids are naturally occurring compounds used in various medical applications.
  • Misuse occurs particularly in athletic contexts to enhance muscle mass and performance.
  • Risks include increased aggressive behavior, weight gain, and skin issues.
  • Withdrawal leads to symptoms opposite to overdose, such as weight loss and behavioral changes.

Public Health Strategies for Addiction

  • Three-pronged strategy:
    1. Primary Prevention: Focus on stopping drug use before it begins, especially in children and teenagers through community programs.
    • Peer pressure is a significant barrier in prevention efforts.
    1. Treatment Resources: Shift from penalization of drug users to viewing them as victims in need of help.
    • Approximately 25% of adults using drugs monthly will require treatment.
    • Many deny their problem, similar to alcohol abusers.
    1. Market Disruption: Efforts to decrease drug production and increase costs.
    • Effectiveness is limited due to the high profitability of illicit drug trade.

Parental Guidance

  • Importance of open dialogue and strong relationships between parents and children regarding substance use.
  • Equip children with the skills to resist peer pressure and to understand their self-worth beyond being part of the crowd.
  • Encourage involvement in community activities to provide constructive alternatives to substance use.

Additional Considerations and Legal Aspects

  • Discussion of safe injection sites and needle exchange programs varies by state and locality, with legality in progressive states like California but not in more conservative areas.
  • Opioid addiction has increasingly spread to rural areas, which often lack resources and support infrastructure for treatment.